p53 is present in synapses where it mediates mitochondrial dysfunction and synaptic degeneration in response to DNA damage, and oxidative and excitotoxic insults
A form of programmed cell-death called apoptosis occurs in neurons during development of the nervous system, and may also occur in a variety of neuropathological conditions. Here we present evidence obtained in studies of adult mice and neuronal cell cultures showing that p53 protein is present in s...
Gespeichert in:
Veröffentlicht in: | Neuromolecular medicine 2003-01, Vol.3 (3), p.159-172 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 172 |
---|---|
container_issue | 3 |
container_start_page | 159 |
container_title | Neuromolecular medicine |
container_volume | 3 |
creator | Gilman, Charles P Chan, Sic L Guo, Zhihong Zhu, Xiaoxiang Greig, Nigel Mattson, Mark P |
description | A form of programmed cell-death called apoptosis occurs in neurons during development of the nervous system, and may also occur in a variety of neuropathological conditions. Here we present evidence obtained in studies of adult mice and neuronal cell cultures showing that p53 protein is present in synapses where its level and amount of phosphorylation are increased following exposure of the cells to the DNA-damaging agent etoposide. We also show that levels of active p53 increase in isolated cortical synaptosomes exposed to oxidative and excitotoxic insults. Increased levels of p53 also precede loss of synapsin I immunoreactive terminals in cultured hippocampal neurons exposed to etoposide. Synaptosomes from p53-deficient mice exhibit increased resistance to oxidative and excitotoxic insults as indicated by stabilization of mitochondrial membrane potential and decreased production of reactive oxygen species. Finally, we show that a synthetic inhibitor of p53 (PFT-alpha) protects synaptosomes from wild-type mice against oxidative and excitotoxic injuries, and preserves presynaptic terminals in cultured hippocampal neurons exposed to etoposide. Collectively, these findings provide the first evidence for a local transcription-independent action of p53 in synapses, and suggest that such a local action of p53 may contribute to the dysfunction and degeneration of synapses that occurs in various neurodegenerative disorders. |
doi_str_mv | 10.1385/NMM:3:3:159 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_883438701</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2425583861</sourcerecordid><originalsourceid>FETCH-LOGICAL-c312t-c1ee8c523b653dff955f3dc8b349e2dfbb693434d4d4fbcb7e1b25b5dc94e7083</originalsourceid><addsrcrecordid>eNpNUctOwzAQtBCI94k7srhCIY5j6nCreEstXOAc-bEBo9YOtgP0c_hTlrYSaA5e787MSjuEHLDilHEpzh4mkwuOYKJeI9tMcDFghazW_9VbZCelt6IoS8bYJtlipeRCMLZNvjvBqUu0i5DAZ-o8TXOvugSJfr5CBOoynYF1KmNn5nIwr8Hb6NSU2nlqe2-yC54qb5fC7Ay18AIeolpM0BG9u-AT0Bzo1cOIWjVTL3CyEIUvZ5H4AYsffBlckbFpUJj6aU57ZKNV0wT7q3eXPN9cP13eDcaPt_eXo_HAcFbmgWEA0oiS63PBbdvWQrTcGql5VUNpW63Pa17xyiJabfQQmC6FFtbUFQwLyXfJ0dK3i-G9h5Sbt9BHjysbKVEphwVD0vGSZGJIKULbdNHNVJw3rGh-02gwjYYjMA1kH64se403_OOuzs9_ALR2iUU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>883438701</pqid></control><display><type>article</type><title>p53 is present in synapses where it mediates mitochondrial dysfunction and synaptic degeneration in response to DNA damage, and oxidative and excitotoxic insults</title><source>MEDLINE</source><source>SpringerLink (Online service)</source><creator>Gilman, Charles P ; Chan, Sic L ; Guo, Zhihong ; Zhu, Xiaoxiang ; Greig, Nigel ; Mattson, Mark P</creator><creatorcontrib>Gilman, Charles P ; Chan, Sic L ; Guo, Zhihong ; Zhu, Xiaoxiang ; Greig, Nigel ; Mattson, Mark P</creatorcontrib><description>A form of programmed cell-death called apoptosis occurs in neurons during development of the nervous system, and may also occur in a variety of neuropathological conditions. Here we present evidence obtained in studies of adult mice and neuronal cell cultures showing that p53 protein is present in synapses where its level and amount of phosphorylation are increased following exposure of the cells to the DNA-damaging agent etoposide. We also show that levels of active p53 increase in isolated cortical synaptosomes exposed to oxidative and excitotoxic insults. Increased levels of p53 also precede loss of synapsin I immunoreactive terminals in cultured hippocampal neurons exposed to etoposide. Synaptosomes from p53-deficient mice exhibit increased resistance to oxidative and excitotoxic insults as indicated by stabilization of mitochondrial membrane potential and decreased production of reactive oxygen species. Finally, we show that a synthetic inhibitor of p53 (PFT-alpha) protects synaptosomes from wild-type mice against oxidative and excitotoxic injuries, and preserves presynaptic terminals in cultured hippocampal neurons exposed to etoposide. Collectively, these findings provide the first evidence for a local transcription-independent action of p53 in synapses, and suggest that such a local action of p53 may contribute to the dysfunction and degeneration of synapses that occurs in various neurodegenerative disorders.</description><identifier>ISSN: 1535-1084</identifier><identifier>EISSN: 1535-1084</identifier><identifier>EISSN: 1559-1174</identifier><identifier>DOI: 10.1385/NMM:3:3:159</identifier><identifier>PMID: 12835511</identifier><language>eng</language><publisher>United States: Springer Nature B.V</publisher><subject>Animals ; Apoptosis ; Benzothiazoles ; Brain - drug effects ; Brain - metabolism ; Brain - physiopathology ; Cell death ; Cells, Cultured ; Cellular biology ; Deoxyribonucleic acid ; DNA ; DNA damage ; DNA Damage - drug effects ; DNA Damage - genetics ; Etoposide ; Etoposide - pharmacology ; Excitotoxicity ; Hippocampus ; Membrane potential ; Membrane Potentials - drug effects ; Membrane Potentials - genetics ; Mice ; Mitochondria ; Mitochondria - drug effects ; Mitochondria - genetics ; Mitochondria - metabolism ; Nervous system ; Neurodegeneration ; Neurodegenerative diseases ; Neurodegenerative Diseases - genetics ; Neurodegenerative Diseases - metabolism ; Neurodegenerative Diseases - physiopathology ; Neurology ; Neurons ; Neuroprotective Agents - pharmacology ; Neurotoxins - pharmacology ; Nucleic Acid Synthesis Inhibitors - pharmacology ; Oxidative Stress - drug effects ; Oxidative Stress - genetics ; p53 Protein ; Phosphorylation ; Presynaptic Terminals - drug effects ; Presynaptic Terminals - metabolism ; Presynaptic Terminals - pathology ; Proteins ; Reactive oxygen species ; Reactive Oxygen Species - metabolism ; Synapsin I ; Synapsins - metabolism ; Synaptosomes ; Thiazoles - pharmacology ; Toluene - analogs & derivatives ; Toluene - pharmacology ; Tumor Suppressor Protein p53 - genetics ; Tumor Suppressor Protein p53 - metabolism</subject><ispartof>Neuromolecular medicine, 2003-01, Vol.3 (3), p.159-172</ispartof><rights>Humana Press Inc 2003.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c312t-c1ee8c523b653dff955f3dc8b349e2dfbb693434d4d4fbcb7e1b25b5dc94e7083</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27928,27929</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12835511$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gilman, Charles P</creatorcontrib><creatorcontrib>Chan, Sic L</creatorcontrib><creatorcontrib>Guo, Zhihong</creatorcontrib><creatorcontrib>Zhu, Xiaoxiang</creatorcontrib><creatorcontrib>Greig, Nigel</creatorcontrib><creatorcontrib>Mattson, Mark P</creatorcontrib><title>p53 is present in synapses where it mediates mitochondrial dysfunction and synaptic degeneration in response to DNA damage, and oxidative and excitotoxic insults</title><title>Neuromolecular medicine</title><addtitle>Neuromolecular Med</addtitle><description>A form of programmed cell-death called apoptosis occurs in neurons during development of the nervous system, and may also occur in a variety of neuropathological conditions. Here we present evidence obtained in studies of adult mice and neuronal cell cultures showing that p53 protein is present in synapses where its level and amount of phosphorylation are increased following exposure of the cells to the DNA-damaging agent etoposide. We also show that levels of active p53 increase in isolated cortical synaptosomes exposed to oxidative and excitotoxic insults. Increased levels of p53 also precede loss of synapsin I immunoreactive terminals in cultured hippocampal neurons exposed to etoposide. Synaptosomes from p53-deficient mice exhibit increased resistance to oxidative and excitotoxic insults as indicated by stabilization of mitochondrial membrane potential and decreased production of reactive oxygen species. Finally, we show that a synthetic inhibitor of p53 (PFT-alpha) protects synaptosomes from wild-type mice against oxidative and excitotoxic injuries, and preserves presynaptic terminals in cultured hippocampal neurons exposed to etoposide. Collectively, these findings provide the first evidence for a local transcription-independent action of p53 in synapses, and suggest that such a local action of p53 may contribute to the dysfunction and degeneration of synapses that occurs in various neurodegenerative disorders.</description><subject>Animals</subject><subject>Apoptosis</subject><subject>Benzothiazoles</subject><subject>Brain - drug effects</subject><subject>Brain - metabolism</subject><subject>Brain - physiopathology</subject><subject>Cell death</subject><subject>Cells, Cultured</subject><subject>Cellular biology</subject><subject>Deoxyribonucleic acid</subject><subject>DNA</subject><subject>DNA damage</subject><subject>DNA Damage - drug effects</subject><subject>DNA Damage - genetics</subject><subject>Etoposide</subject><subject>Etoposide - pharmacology</subject><subject>Excitotoxicity</subject><subject>Hippocampus</subject><subject>Membrane potential</subject><subject>Membrane Potentials - drug effects</subject><subject>Membrane Potentials - genetics</subject><subject>Mice</subject><subject>Mitochondria</subject><subject>Mitochondria - drug effects</subject><subject>Mitochondria - genetics</subject><subject>Mitochondria - metabolism</subject><subject>Nervous system</subject><subject>Neurodegeneration</subject><subject>Neurodegenerative diseases</subject><subject>Neurodegenerative Diseases - genetics</subject><subject>Neurodegenerative Diseases - metabolism</subject><subject>Neurodegenerative Diseases - physiopathology</subject><subject>Neurology</subject><subject>Neurons</subject><subject>Neuroprotective Agents - pharmacology</subject><subject>Neurotoxins - pharmacology</subject><subject>Nucleic Acid Synthesis Inhibitors - pharmacology</subject><subject>Oxidative Stress - drug effects</subject><subject>Oxidative Stress - genetics</subject><subject>p53 Protein</subject><subject>Phosphorylation</subject><subject>Presynaptic Terminals - drug effects</subject><subject>Presynaptic Terminals - metabolism</subject><subject>Presynaptic Terminals - pathology</subject><subject>Proteins</subject><subject>Reactive oxygen species</subject><subject>Reactive Oxygen Species - metabolism</subject><subject>Synapsin I</subject><subject>Synapsins - metabolism</subject><subject>Synaptosomes</subject><subject>Thiazoles - pharmacology</subject><subject>Toluene - analogs & derivatives</subject><subject>Toluene - pharmacology</subject><subject>Tumor Suppressor Protein p53 - genetics</subject><subject>Tumor Suppressor Protein p53 - metabolism</subject><issn>1535-1084</issn><issn>1535-1084</issn><issn>1559-1174</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNpNUctOwzAQtBCI94k7srhCIY5j6nCreEstXOAc-bEBo9YOtgP0c_hTlrYSaA5e787MSjuEHLDilHEpzh4mkwuOYKJeI9tMcDFghazW_9VbZCelt6IoS8bYJtlipeRCMLZNvjvBqUu0i5DAZ-o8TXOvugSJfr5CBOoynYF1KmNn5nIwr8Hb6NSU2nlqe2-yC54qb5fC7Ay18AIeolpM0BG9u-AT0Bzo1cOIWjVTL3CyEIUvZ5H4AYsffBlckbFpUJj6aU57ZKNV0wT7q3eXPN9cP13eDcaPt_eXo_HAcFbmgWEA0oiS63PBbdvWQrTcGql5VUNpW63Pa17xyiJabfQQmC6FFtbUFQwLyXfJ0dK3i-G9h5Sbt9BHjysbKVEphwVD0vGSZGJIKULbdNHNVJw3rGh-02gwjYYjMA1kH64se403_OOuzs9_ALR2iUU</recordid><startdate>20030101</startdate><enddate>20030101</enddate><creator>Gilman, Charles P</creator><creator>Chan, Sic L</creator><creator>Guo, Zhihong</creator><creator>Zhu, Xiaoxiang</creator><creator>Greig, Nigel</creator><creator>Mattson, Mark P</creator><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7QR</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope></search><sort><creationdate>20030101</creationdate><title>p53 is present in synapses where it mediates mitochondrial dysfunction and synaptic degeneration in response to DNA damage, and oxidative and excitotoxic insults</title><author>Gilman, Charles P ; Chan, Sic L ; Guo, Zhihong ; Zhu, Xiaoxiang ; Greig, Nigel ; Mattson, Mark P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c312t-c1ee8c523b653dff955f3dc8b349e2dfbb693434d4d4fbcb7e1b25b5dc94e7083</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Animals</topic><topic>Apoptosis</topic><topic>Benzothiazoles</topic><topic>Brain - drug effects</topic><topic>Brain - metabolism</topic><topic>Brain - physiopathology</topic><topic>Cell death</topic><topic>Cells, Cultured</topic><topic>Cellular biology</topic><topic>Deoxyribonucleic acid</topic><topic>DNA</topic><topic>DNA damage</topic><topic>DNA Damage - drug effects</topic><topic>DNA Damage - genetics</topic><topic>Etoposide</topic><topic>Etoposide - pharmacology</topic><topic>Excitotoxicity</topic><topic>Hippocampus</topic><topic>Membrane potential</topic><topic>Membrane Potentials - drug effects</topic><topic>Membrane Potentials - genetics</topic><topic>Mice</topic><topic>Mitochondria</topic><topic>Mitochondria - drug effects</topic><topic>Mitochondria - genetics</topic><topic>Mitochondria - metabolism</topic><topic>Nervous system</topic><topic>Neurodegeneration</topic><topic>Neurodegenerative diseases</topic><topic>Neurodegenerative Diseases - genetics</topic><topic>Neurodegenerative Diseases - metabolism</topic><topic>Neurodegenerative Diseases - physiopathology</topic><topic>Neurology</topic><topic>Neurons</topic><topic>Neuroprotective Agents - pharmacology</topic><topic>Neurotoxins - pharmacology</topic><topic>Nucleic Acid Synthesis Inhibitors - pharmacology</topic><topic>Oxidative Stress - drug effects</topic><topic>Oxidative Stress - genetics</topic><topic>p53 Protein</topic><topic>Phosphorylation</topic><topic>Presynaptic Terminals - drug effects</topic><topic>Presynaptic Terminals - metabolism</topic><topic>Presynaptic Terminals - pathology</topic><topic>Proteins</topic><topic>Reactive oxygen species</topic><topic>Reactive Oxygen Species - metabolism</topic><topic>Synapsin I</topic><topic>Synapsins - metabolism</topic><topic>Synaptosomes</topic><topic>Thiazoles - pharmacology</topic><topic>Toluene - analogs & derivatives</topic><topic>Toluene - pharmacology</topic><topic>Tumor Suppressor Protein p53 - genetics</topic><topic>Tumor Suppressor Protein p53 - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gilman, Charles P</creatorcontrib><creatorcontrib>Chan, Sic L</creatorcontrib><creatorcontrib>Guo, Zhihong</creatorcontrib><creatorcontrib>Zhu, Xiaoxiang</creatorcontrib><creatorcontrib>Greig, Nigel</creatorcontrib><creatorcontrib>Mattson, Mark P</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Health Medical collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Psychology Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><jtitle>Neuromolecular medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gilman, Charles P</au><au>Chan, Sic L</au><au>Guo, Zhihong</au><au>Zhu, Xiaoxiang</au><au>Greig, Nigel</au><au>Mattson, Mark P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>p53 is present in synapses where it mediates mitochondrial dysfunction and synaptic degeneration in response to DNA damage, and oxidative and excitotoxic insults</atitle><jtitle>Neuromolecular medicine</jtitle><addtitle>Neuromolecular Med</addtitle><date>2003-01-01</date><risdate>2003</risdate><volume>3</volume><issue>3</issue><spage>159</spage><epage>172</epage><pages>159-172</pages><issn>1535-1084</issn><eissn>1535-1084</eissn><eissn>1559-1174</eissn><abstract>A form of programmed cell-death called apoptosis occurs in neurons during development of the nervous system, and may also occur in a variety of neuropathological conditions. Here we present evidence obtained in studies of adult mice and neuronal cell cultures showing that p53 protein is present in synapses where its level and amount of phosphorylation are increased following exposure of the cells to the DNA-damaging agent etoposide. We also show that levels of active p53 increase in isolated cortical synaptosomes exposed to oxidative and excitotoxic insults. Increased levels of p53 also precede loss of synapsin I immunoreactive terminals in cultured hippocampal neurons exposed to etoposide. Synaptosomes from p53-deficient mice exhibit increased resistance to oxidative and excitotoxic insults as indicated by stabilization of mitochondrial membrane potential and decreased production of reactive oxygen species. Finally, we show that a synthetic inhibitor of p53 (PFT-alpha) protects synaptosomes from wild-type mice against oxidative and excitotoxic injuries, and preserves presynaptic terminals in cultured hippocampal neurons exposed to etoposide. Collectively, these findings provide the first evidence for a local transcription-independent action of p53 in synapses, and suggest that such a local action of p53 may contribute to the dysfunction and degeneration of synapses that occurs in various neurodegenerative disorders.</abstract><cop>United States</cop><pub>Springer Nature B.V</pub><pmid>12835511</pmid><doi>10.1385/NMM:3:3:159</doi><tpages>14</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1535-1084 |
ispartof | Neuromolecular medicine, 2003-01, Vol.3 (3), p.159-172 |
issn | 1535-1084 1535-1084 1559-1174 |
language | eng |
recordid | cdi_proquest_journals_883438701 |
source | MEDLINE; SpringerLink (Online service) |
subjects | Animals Apoptosis Benzothiazoles Brain - drug effects Brain - metabolism Brain - physiopathology Cell death Cells, Cultured Cellular biology Deoxyribonucleic acid DNA DNA damage DNA Damage - drug effects DNA Damage - genetics Etoposide Etoposide - pharmacology Excitotoxicity Hippocampus Membrane potential Membrane Potentials - drug effects Membrane Potentials - genetics Mice Mitochondria Mitochondria - drug effects Mitochondria - genetics Mitochondria - metabolism Nervous system Neurodegeneration Neurodegenerative diseases Neurodegenerative Diseases - genetics Neurodegenerative Diseases - metabolism Neurodegenerative Diseases - physiopathology Neurology Neurons Neuroprotective Agents - pharmacology Neurotoxins - pharmacology Nucleic Acid Synthesis Inhibitors - pharmacology Oxidative Stress - drug effects Oxidative Stress - genetics p53 Protein Phosphorylation Presynaptic Terminals - drug effects Presynaptic Terminals - metabolism Presynaptic Terminals - pathology Proteins Reactive oxygen species Reactive Oxygen Species - metabolism Synapsin I Synapsins - metabolism Synaptosomes Thiazoles - pharmacology Toluene - analogs & derivatives Toluene - pharmacology Tumor Suppressor Protein p53 - genetics Tumor Suppressor Protein p53 - metabolism |
title | p53 is present in synapses where it mediates mitochondrial dysfunction and synaptic degeneration in response to DNA damage, and oxidative and excitotoxic insults |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-17T13%3A44%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=p53%20is%20present%20in%20synapses%20where%20it%20mediates%20mitochondrial%20dysfunction%20and%20synaptic%20degeneration%20in%20response%20to%20DNA%20damage,%20and%20oxidative%20and%20excitotoxic%20insults&rft.jtitle=Neuromolecular%20medicine&rft.au=Gilman,%20Charles%20P&rft.date=2003-01-01&rft.volume=3&rft.issue=3&rft.spage=159&rft.epage=172&rft.pages=159-172&rft.issn=1535-1084&rft.eissn=1535-1084&rft_id=info:doi/10.1385/NMM:3:3:159&rft_dat=%3Cproquest_cross%3E2425583861%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=883438701&rft_id=info:pmid/12835511&rfr_iscdi=true |